Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Idiopathic interstitial pneumonias (IIPs) have a progressive and often fatal course, and their enigmatic etiology has complicated approaches to effective therapies. Idiopathic pulmonary fibrosis (IPF) is the most common of IIPs and shares with IIPs an increased incidence with age and unexplained scarring in the lung. Short telomeres limit tissue renewal capacity in the lung and germ-line mutations in telomerase components, hTERT and hTR , underlie inheritance in a subset of families with IPF. To examine the hypothesis that short telomeres contribute to disease risk in sporadic IIPs, we recruited patients who have no family history and examined telomere length in leukocytes and in alveolar cells. To screen for mutations, we sequenced hTERT and hTR. We also reviewed the cases for features of a telomere syndrome. IIP patients had shorter leukocyte telomeres than age-matched controls ( P < 0.0001). In a subset (10%), IIP patients had telomere lengths below the first percentile for their age. Similar to familial cases with mutations, IPF patients had short telomeres in alveolar epithelial cells ( P < 0.0001). Although telomerase mutations were rare, detected in 1 of 100 patients, we identified a cluster of individuals (3%) with IPF and cryptogenic liver cirrhosis, another feature of a telomere syndrome. Short telomeres are thus a signature in IIPs and likely play a role in their age-related onset. The clustering of cryptogenic liver cirrhosis with IPF suggests that the telomere shortening we identify has consequences and can contribute to what appears clinically as idiopathic progressive organ failure in the lung and the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, patients with IPF who have mutant telomerase genes are at an increased risk of developing bone marrow failure and liver disease54,71.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, telomere dysfunction in epithelial cells, or perhaps another cell type, might cause parenchymal organ remodelling, which manifests as fibrosis and/or emphysema46,54,99.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, circulating leukocytes and alveolar epithelial cells show shorter telomeres than age-matched individuals53.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“The frequency of these mutations is highest in individuals with the progressive disorder IPF, which accounts for 8–15% of familial and 1–3% of sporadic cases54,56,68,69.”
From The telomere syndromes (2012) · cites this paper as [54]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Lead SNPs at two loci (TERC and TERT) associate with several cancers and other diseases, including idiopathic pulmonary fibrosis.”
From Identification of seven loci affecting mean telomere length and their association with disease (2013) · cites this paper as [26]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 6×
“In IPF families with telomerase mutations, cases of aplastic anemia can be hidden and are uncovered after a thorough family history, suggesting that mutations in telomerase have heterogeneous manifestations in an individual patient and within families, and that a subset of families with IPF falls on the same spectrum…”
BackgroundInfluentialSelf-citationEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Cited by
Items 501–600 of 802
Circular RNAs and their roles in idiopathic pulmonary fibrosis
Surendran, A. M., Huang, C., & Liu, L. (2024) · Respiratory Research · doi:10.1186/s12931-024-02716-2 · Cited by 14
From bad to worse: when lung cancer complicates idiopathic pulmonary fibrosis
Strock, S. B., Alder, J. K., & Kass, D. J. (2017) · The Journal of Pathology · doi:10.1002/path.5027 · Cited by 14
“Furthermore, mutations in telomere-maintenance genes are the most common identifiable cause of sporadic and familial IPF [18,19] and short telomeres are a risk factor for IPF [20,21].”
BackgroundSelf-citationM’kacher, R., Jaillet, M., Colicchio, B., Vasarmidi, E., Mailleux, A., Dieterlen, A., Kannengiesser, C., Borie, C., Oudrhiri, N., Junker, S., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020310 · Cited by 15
“Reduced telomere length in peripheral blood lymphocytes of IPF patients without TRG mutations have also been reported [31,32], almost all IPF patients having telomere lengths shorter than the median, 25% below the 10th percentile and 10% below the first percentile compared to healthy controls [31].”
BackgroundNew Developments in the Therapy of Pulmonary Fibrosis
Scriabine, A., & Rabin, D. U. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57011-6 · Cited by 14
Garcia, C. K. (2015) · CHEST Journal · doi:10.1378/chest.15-0077 · Cited by 12
Epigenetics alternation in lung fibrosis and lung cancer
Li, X., Feng, C., & Peng, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1060201 · Cited by 11
“In vertebrates, telomeric DNA has consisted of canonical TTAGGG repeats and their length wears away with cell division, limiting the self-renewal ability of the lung, and gradually leading to ageing, death, and apoptosis of alveolar cells (Alder et al., 2008).”
BackgroundMatsubayashi, S., Ito, S., Araya, J., & Kuwano, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1079626 · Cited by 15
“The frequency of telomere shortening is high in patients with sporadic pulmonary fibrosis (75).”
BackgroundShah, P. D., & Armanios, M. Y. (2025) · European Respiratory Journal · doi:10.1183/13993003.01545-2024 · Cited by 11
“5 ) This latter high risk subset of patients represents approximately 10% of all sporadic IPF patients, and a higher proportion of young-onset patients [17] with, likely, a comparable subset of patients with hypersensitivity pneumonitis [48].”
InfluentialSelf-citationInsights into interstitial lung disease pathogenesis
Vasarmidi, E., Worrell, J. C., Persson, I. M., Yaqub, N., Miądlikowska, E., Barnig, C., Boots, A. W., Reynaert, N. L., & Ocaña, S. C. (2025) · Breathe · doi:10.1183/20734735.0261-2024 · Cited by 15
“Importantly, short telomere length has been associated with worse clinical outcome in fibrotic ILDs [12 – 14], increased fibrosis [15, 16] and poor tolerance to immunosuppressive treatments [17 – 20].”
Genetic background of idiopathic pulmonary fibrosis
Santangelo, S., Scarlata, S., Zito, A., Chiurco, D., Pedone, C., & Incalzi, R. A. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.13.22 · Cited by 12
Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases
Dvorak, L. A., Vassallo, R., Kirmani, S., Johnson, G. B., Hartman, T. E., Tazelaar, H. D., Leslie, K. O., Colby, T. V., Cockcroft, D. W., Churg, A., et al. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.10.003 · Cited by 11
“more severe defects in lung repair mechanism [4].”
BackgroundJang, S., Ryu, S. M., Lee, J. Y., Lee, H., Hong, S.-H., Ha, K., Park, W. S., Han, E., & Yang, S. (2018) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2017.0124 · Cited by 12
Treating IPF—all or nothing? A PRO‐CON debate
Behr, J., Kolb, M. R. J., & Cox, G. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01645.x · Cited by 11
Familial Interstitial Pneumonia
Talbert, J. L., Schwartz, D. A., & Steele, M. P. (2014) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000034 · Cited by 13
“This process has been implicated in age-related diseases.(43) Telomerase mutations in TERT and TERC associated with FIP were first reported by 2 independent groups in 2007 using different approaches.”
BackgroundMethodThe STATus of STAT3 in Lung Cell Senescence?
Adnot, S., Lipskaia, L., & Bernard, D. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0013ed · Cited by 11
ISHLT Consensus Statement on Short Telomere Syndrome and Lung Transplantation
Courtwright, A., Mackintosh, J. A., Alder, J. K., Garcia, C. K., Froidure, A., Lowery, E. M., Hayes, D., Pali, S., Philippot, Q., Borie, R., et al. (2026) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.10.028 · Cited by 12
Self-citationKoteci, A., Morgan, A. D., Portas, L., Whittaker, H., Kallis, C., George, P., & Quint, J. K. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01973-5 · Cited by 12
“Given that CVDs such as IHD, hypertension and atrial fibrillation can all contribute to the pathophysiology of left-sided HF and that both IPF and HF share similar pathophysiological mechanisms such as cellular senescence [14, 15], it unsurprising that IPF and HF often co-exist.”
BackgroundA Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis
Blackwell, T. S., Hewlett, J. C., Mason, W. R., Martin, S., Greco, J. D., Ding, G., Wu, P., LANCASTER, L. H., Loyd, J. E., Dudenhofer, R. B., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202102-108oc · Cited by 11
Self-citationSabater, L., Gossart, J. B., Hernandez, I., Rico, D., Blanchard, A. D., Borthwick, L. A., Fisher, A. J., Majo, J., Jiwa, K., Collins, A., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.12.015 · Cited by 11
Tomita, K., Caramori, G., Ito, K., Lim, S., Sano, H., Tohda, Y., Adcock, I. M., & Barnes, P. J. (2010) · The Open Pathology Journal · doi:10.2174/1874375701004010023 · Cited by 12
Sandbo, N. K. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_8 · Cited by 13
Mechanisms and markers of lung ageing in health and disease
Miller, Z., Twardowski, L.-M., Reader, B. F., Rojas, M. M., Lehmann, M., & Mora, A. L. (2025) · European Respiratory Review · doi:10.1183/16000617.0233-2024 · Cited by 14
Benedittis, G. D., Latini, A., Morgante, C., Bonini, C., Cela, E., Kroegler, B., Luciano, A., Chiocchi, M., Cavalli, F., Ora, J., et al. (2025) · Autoimmunity · doi:10.1080/08916934.2025.2473741 · Cited by 11
“Shortened telomeres have been described in RA and idiopathic pulmonary fibrosis [12,13].”
Management of interstitial lung disease in elderly patients
Meyer, K. C. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283541337 · Cited by 10
“Unau 1070-5287 2012 Wolters Kluwer Health | Lippincott Williams & Wilk matched controls [16].”
BackgroundHeidary, H., Pouresmaeili, F., Mirfakhraie, R., Omrani, M. D., Ghaedi, H., Fazeli, Z., Sayban, S., Ghafouri‐Fard, S., Azargashb, E., & Shokri, F. (2018) · Iranian Biomedical Journal · doi:10.29252/ibj.22.4.231 · Cited by 10
Martínez, P., Sánchez-Vazquez, R., Saha, A., Rodríguez-Duque, M. S., Naranjo-Gonzalo, S., Osorio-Chávez, J. S., Villar, A. V., & Blasco, M. A. (2023) · Aging · doi:10.18632/aging.204755 · Cited by 11
Short telomeres: a repeat offender in IPF
Stanley, S. E., & Armanios, M. Y. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70140-7 · Cited by 9
Self-citationChoi, H. K., Bang, G., Shin, J. H., Shin, M. H., Woo, A., Kim, S. Y., Lee, S. H., Kim, E. Y., Shim, H. S., Suh, Y. J., et al. (2024) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2024.0094 · Cited by 9
Merino, A. M., Hoogduijn, M. J., Molina‐Molina, M., Arias‐Salgado, E. G., Korevaar, S. S., Baan, C. C., & Montes‐Worboys, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248415 · Cited by 9
“It has been described that telomere length is correlated with the clinical outcome of IPF patients [5].”
BackgroundNelson, N. E., Feurstein, S. K., Niaz, A., Truong, J. Q., Holien, J. K., Lucas, S. E. M., Fairfax, K. A., Dickinson, J. L., & Bryan, T. M. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.11.021 · Cited by 11
High-throughput single telomere analysis using DNA microarray and fluorescent in situ hybridization
Zheng, Y., Wu, X., Williams, M., Verhulst, S., Lin, J., Takahashi, Y., Ma, J., & Wang, Y. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae812 · Cited by 9
“Short telomere length has been implicated as a risk factor in pulmonary disease ( 19–21 ), diabetes mellitus ( 22–24 ), liver cirrhosis ( 25 ,26 ), osteoporosis ( 27 ,28 ), kidney disease ( 29 ,30 ), Alzheimer’s disease ( 31 ,32 ), cardiovascular disease ( 33 ,34 ), and cancer ( 35 ,36 ).”
Genetic testing in diffuse parenchymal lung disease
Spagnolo, P., Luppi, F., Cerri, S., & Richeldi, L. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-79 · Cited by 8
“Mutations in TERT and TERC account for 815% of familial and 1-3% of sporadic cases [18,19], but short telomere length is a more common finding in IPF - with sporadic IPF cases displaying significantly shorter telomeres compared to age-matched controls - even in the absence of telomerase mutations [20].”
BackgroundUBQLN1 deficiency mediates telomere shortening and IPF through interacting with RPA1
Zhou, H., Xie, C., Xie, Y., He, Y., Chen, Y., Zhang, C., Zhang, Y., Zhao, Y. B., & Liu, H. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010856 · Cited by 8
“Previous studies found that the leucocyte telomere lengths are shorter in patients with IPF than those with other interstitial lung diseases [44,45], and a recent mendelian randomization study using a pretty large IPF cohort (more than 3000 IPFs) demonstrated that prematurely telomere shortening is likely a cause of I…”
BackgroundContributions of Telomere Biology to Human Age-Related Disease
Yang, T.-L., Song, S., & Johnson, F. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00007-1 · Cited by 11
Molecular Diagnosis and Precision Therapeutic Approaches for Telomere Biology Disorders
Perona, R., Iarriccio, L., Pintado‐Berninches, L., Rodríguez-Centeno, J., Manguán-García, C., Garcia, E., López‐Ayllón, B. D., & Sastre, L. (2016) · InTech eBooks · doi:10.5772/65353 · Cited by 12
“Heterozygous mutations in genes coding for telomere-related proteins have been found in 15-20% of IPF families without a history of DC [162, 163, 166] and 1-3% of sporadic cases of IPF [167].”
InfluentialMathematical model to study the aging of the human follicle according to the telomerase activity
Portillo, A. M., Varela, E., & García-Velasco, J. A. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.11.036 · Cited by 8
Pleuroparenchymal Fibroelastosis after Liver Transplantation
Goondi, D., Franko, A., & Johannson, K. A. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3432im · Cited by 8
Keeling, B. H., Antia, C., Steadmon, M. J., Wesson, S. K., & Williams, C. H. (2014) · Dermatology Online Journal · doi:10.5070/d3209023917 · Cited by 8
Parra, E. R., Pincelli, M. S., Teodoro, W. R., Velosa, A. P. P., Martins, V., Rangel, M. P., Barbas‐Filho, J. V., & Capelozzi, V. L. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143522 · Cited by 8
“(31) identified a cluster of individuals with IPF and cryptogenic liver cirrhosis, suggesting that the identified telomere shortening could contribute to what clinically appears as idiopathic progressive organ failure in the lung and the liver.”
BackgroundMan, L., & Peng, H. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.213423 · Cited by 8
“[3‐5] A significantly higher proportion of patients with IPF display shorter telomeres in peripheral blood and in alveolar epithelial cells, as compared to controls.[3,4] A meta‐analysis shows that the MUC5B promoter rs35705950 polymorphism is strongly associated with the risk of IPF,[6] the result has been confirmed…”
ResultWill the Genes Responsible for Familial Pulmonary Fibrosis Provide Clues to the Pathogenesis of IPF?
Lawson, W. E., & Loyd, J. E. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201007-1193ed · Cited by 8
Self-citationKoskela, J. T., Häppölä, P., Liu, A., FinnGen, Partanen, J., Genovese, G., Artomov, M., Myllymäki, M., Kanai, M., Zhou, W., et al. (2021) · medRxiv · doi:10.1101/2021.05.07.21255988 · Cited by 10
Enhanced Expression of a Novel Lamin A/C Splice Variant in Idiopathic Pulmonary Fibrosis Lung
Yin, Q., Morris, G. F., Saito, S., Zhuang, Y., Thannickal, V. J., Jazwinski, S. M., & Lasky, J. A. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0222oc · Cited by 7
Kılıç, K., Erışık, D., Taşkıran, D., Turhan, K., Kose, T., Cetin, E. O., Şendemir, A., & Uyanikgil, Y. (2024) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2024.117016 · Cited by 7
Genetics of interstitial lung diseases: a state-of-the-art review
Ng, N., Molina‐Molina, M., Adegunsoye, A., Borie, R., Newton, C. A., Raby, B. A., Zhang, D., Padilla, M. L., Crestani, B., Horwitz, M. S., et al. (2025) · European Respiratory Journal · doi:10.1183/13993003.00788-2025 · Cited by 9
Lv, H., Qian, X., Tao, Z., Shu, J., Shi, D., Yu, J., Fan, G., Qian, Q., Shen, L., & Lü, B. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1145 · Cited by 7
Perrotta, F., D’Agnano, V., Mariniello, D. F., Castaldo, G., Vitale, M., Cazzola, M., Bianco, A., & Scialò, F. (2024) · Respiratory Research · doi:10.1186/s12931-024-02796-0 · Cited by 8
Short telomeres in pulmonary fibrosis: from genetics to clinical significance.
Trăilă, D., Firă-Mladinescu, O., Oancea, C. I., & Tudorache, V. (2015) · PubMed · Cited by 7
Telomerase and Cancer: A Complex Relationship
Fossel, M., & Whittemore, K. (2021) · OBM Geriatrics · doi:10.21926/obm.geriatr.2101156 · Cited by 7
Sadhukhan, R., & Ghosh, U. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119556 · Cited by 7
Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review
Ding, D., Gao, R., Xue, Q., Luan, R., & Yang, J. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.80358 · Cited by 8
“One study showed that 97% of patients with IPF have shorter telomeres than age- and sex-matched controls (100), suggesting that short telomeres are not only found in patients with telomerase-related gene mutations associated with f-IPF.”
BackgroundWare, L. B. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200907-057tt · Cited by 8
Portillo, A. M., & Peláez-Rodríguez, C. (2021) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqab004 · Cited by 7
Getting to the core of fibrosis: targeting redox imbalance in aging
Hecker, L., & Thannickal, V. J. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2015.12.45 · Cited by 8
“Recent studies of familial and sporadic cases of IPF have been associated with telomere shortening (22,23), further supporting the concept that IPF may represent an age-related degenerative disease process (24).”
BackgroundDiagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders
del Valle, K. T., & Carmona, E. M. (2023) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-023-00720-9 · Cited by 7
“Several studies have shown that mutations in telomere-related genes are commonly implicated in these cases [10, 11].”
Elliot, S. J., Anderson-Bell, D., Roos, B. B., Rubio, G. A., Xia, X., Pereira‐Simon, S., Catanuto, P., Civettini, G., Hagen, E. S., Arvanitis, C., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102461 · Cited by 6
“33,80 Furthermore, induction of telomerase de fi ciency or telomere dysfunction in murine models is associated with a propensity for the subsequent development of PF in synergy with a low dose of BLM, 81 while treatment of wild-type and telomerase-de fi cient mice with telomerase gene therapy…”
Yang, M. M., Liu, S., Wax, M., Lee, S., French, S., Wolters, P. J., & Boin, F. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43400 · Cited by 7
Fueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease
Kliment, C. R., Gurkar, A. U., Cárdenes, N., Ramonell, R. P., Finkel, T., & Königshoff, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00024.2025 · Cited by 7
Dong, Z., Wang, X., Wang, P., Bai, M., Wang, T., Chu, Y., & Qin, Y. (2024) · Advanced Biology · doi:10.1002/adbi.202400297 · Cited by 6
Telomeropathies in Interstitial Lung Disease and Lung Transplant Recipients
Southern, B. D., & Gadre, S. K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051496 · Cited by 11
“First, it has been shown that patients with IPF, irrespective of whether there is a telomere mutation, have short telomeres compared to the population, with approximately half having a leukocyte telomere length (LTL) below the 10th age-adjusted percentile [49].”
Contemporary Concise Review 2019: Interstitial lung disease
George, P. M., & Wells, A. U. (2020) · Respirology · doi:10.1111/resp.13803 · Cited by 6
Defining the Genetic Landscape of Idiopathic Pulmonary Fibrosis: Role of Common and Rare Variants
Moss, B. J., & Rosas, I. O. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0177ed · Cited by 6
O'Connor, T. E., Shaw, R. C., Madero‐Marroquin, R., & Roloff, G. W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1180439 · Cited by 6
“The loss of function of these genes lead to a variable phenotypic presentation that includes non-hematopoietic phenotypes including idiopathic pulmonary fibrosis (27), premature graying of hair, cryptogenic cirrhosis, and hematologic consequences including aplastic anemia, MDS, and AML (28, 29).”
BackgroundLuo, W., Gu, Y., Fu, S., Wang, J., Zhang, J., & Wang, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115762 · Cited by 7
Tesolato, S. E., Vicente-Valor, J., Jarabo, J. R., Calatayud, J., Saiz‐Pardo, M., Nieto, A., Álvarez, D. Á., Linares, M.-J., Fraile, C.-A., Hernándo, F., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11123257 · Cited by 8
“One previous work used tissue TL as a biomarker for disease development [22], although the majority of studies have focused on peripheral blood leukocyte TL as a biomarker for the presence of ILD [23].”
MethodAutophagy and Cellular Senescence in Lung Diseases
Kuwano, K., Araya, J., Hara, H., Minagawa, S., Takasaka, N., Ito, S., & Nakayama, K. (2015) · Journal of Biochemistry and Molecular Biology Research · doi:10.17554/j.issn.2313-7177.2015.01.5 · Cited by 6
Radiologic Evaluation of Idiopathic Interstitial Pneumonias
Koelsch, T. L., Chung, J. H., & Lynch, D. A. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.02.009 · Cited by 6
Current Concept for the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
Nho, R. S. (2013) · Cited by 7
Sénescence cellulaire et pathologies pulmonaires : exemple de la BPCO
Boyer, L., Savale, L., Boczkowski, J., & Adnot, S. (2014) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2014.07.015 · Cited by 10
Telomerase and non-Telomerase Mechanisms of Telomere Maintenance
Morrish, T. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73734 · Cited by 8
Kass, D. J., Flynn, M., & Baker, E. (2015) · Current Biomarker Findings · doi:10.2147/cbf.s81362 · Cited by 7
“Similar findings by Alder et al found that nonfamilial IPF patients, even in the absence of familial mutations, have shorter peripheral blood leukocyte telomeres than age-matched controls.(117) Finally, a more recent genome-wide association study identified a common single-nucleotide polymorphism in TOLLIP, a toll-int…”
Zheng, C., Zhan, X., Yang, Y., Jiang, T., Ye, Q., & Lu, Y. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.240802 · Cited by 7
“Among them, rare coding variants in TERT gene which encodes the protein component of telomerase, are found up to 15% of familial IPF and show autosomal dominant transmission with age‐dependent penetrance.[7,8] About 2–20% of cases of idiopathic interstitial pneumonia cluster in families,[9] leading to the potential to…”
BackgroundKliszczak, M., Moralli, D., Jankowska, J. D., Bryjka, P., Meem, L. S., Goncalves, T., Hester, S. S., Fischer, R., Clynes, D., & Green, C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1175069 · Cited by 6
“Premature telomere shortening is detrimental for normal cellular function and has been linked to multiple human diseases including lung fibrosis [reviewed in (Armanios, 2022) and (Armanios et al., 2007; Tsakiri et al., 2007; Alder et al., 2008; Cronkhite et al., 2008; Diaz de Leon et al., 2010)].”
BackgroundInfluentialMathai, S. K., & Schwartz, D. A. (2015) · European Respiratory Journal · doi:10.1183/09031936.00052715 · Cited by 7
Huie, T. J., Moss, M., & Frankel, S. K. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00155.2010 · Cited by 6
“Several studies have demonstrated shortened telomeres in patients with both familial and sporadic IPF, and these suggest that alveolar epithelial senescence contributes to the development of pulmonary fibrosis (1).”
BackgroundShort Telomeres and Treatment of Pulmonary Fibrosis: Implications for Early Intervention
Antoniou, K. M., Papadaki, H. Α., Soufla, G., & Siafakas, N. M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.179.10.970 · Cited by 6
Three Steps to Cure Pulmonary Fibrosis. Step 1: The Runaway Train or Groundhog Day?
Jenkins, G. R. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0260ed · Cited by 6
“Overall, these data support the hypothesis that ILAs are precursor lesions of IPF, the latter presenting late in 60th decade or early in the 70th decade (2), but are also associated with the MUC5B polymorphism and short telomeres (12, 13).”
ResultTelomere Dynamics in Human Health and Disease
Baird, D. M. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041701 · Cited by 7
“While most cases of IPF are sporadic, a subset of individuals with familial IPF have mutations in genes associated with telomere maintenance, such as TERT, TERC, and other shelterin complex components (Alder et al. 2008).”
Alveolar epithelial cells of lung fibrosis patients are susceptible to severe virus-induced injury
Read, J. M., Reid, A. T., Thomson, C., Plit, M., Mejia, R., Knight, D. A., Lizé, M., Kasmi, K. E., Grainge, C., Stahl, H. F., et al. (2024) · Clinical Science · doi:10.1042/cs20240220 · Cited by 5
A persistent variant telomere sequence in a human pedigree
Hinchie, A. M., Sanford, S. L., Loughridge, K. E., Sutton, R. M., Parikh, A. H., Silva, A. A. G., Sullivan, D. I., Chun‐on, P., Morrell, M. R., McDyer, J. F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49072-9 · Cited by 7
Self-citationCerri, S., Manzini, E., Nori, O., Pacchetti, L., Rossi, L., Turchiano, M. G., Samarelli, A. V., Raineri, G., Andrisani, D., Gozzi, F., et al. (2024) · Medicina · doi:10.3390/medicina60121967 · Cited by 7
“The measurement of telomere length in peripheral blood cells is often used as a proxy for detecting telomere mutations [19].”
InfluentialInflammation and dysregulated fibroblast proliferation--new mechanisms?
Kolb, M. R. J. (2013) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 5
Biomarkers in Idiopathic Pulmonary Fibrosis
Stankovic, S. D., Stjepanović, M., & Ašanin, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100042 · Cited by 6
Idiopathic Interstitial Pneumonias
Selman, M., Morrison, L. D., Noble, P. W., & King, T. E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00057-2 · Cited by 8
Šelb, J., Osolnik, K., Kern, I., Korošec, P., & Rijavec, M. (2022) · Cells · doi:10.3390/cells11030372 · Cited by 7
“Short telomeres have long been connected to idiopathic interstitial pneumonias (IIPs); especially to the most common and most deadly of the IIPs, idiopathic pulmonary fibrosis (IPF) [1–3].”
BackgroundInfluentialPeripheral Blood Telomere Attrition in Persons at Risk for Familial Pulmonary Fibrosis
Salisbury, M. L., Markin, C. R., Wu, P., Cogan, J. D., Mitchell, D. B., Liu, Q., Loyd, J. E., LANCASTER, L. H., Kropski, J. A., & Blackwell, T. S. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202204-0766le · Cited by 5
“Fourth, our finding that the %-eMTL in noncarriers of a familial telomerase RV approaches that of carriers is contrary to several publications (3, 4), although the occurrence of PF and short telomeres among noncarriers of a familial RV has been described (18).”
ResultSelf-citationMohning, M. P., Downey, G. P., Cosgrove, G. P., & Redente, E. F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54431-3.00003-2 · Cited by 122
Perona, R. (2010) · Clinical & Translational Oncology · doi:10.1007/s12094-010-0572-y · Cited by 5
“In other diseases, such as idiopathic pulmonary, liver and heart fi brosis, whose origin is chronic infl ammation in at least some patients, mutations in either hTR or hTERT were also found [26, 27 ].”
BackgroundTelomeres in the Clinic, Not on TV
Armanios, M. Y. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.05.024 · Cited by 5
Self-citationMolecular underpinnings of aging contributing to systemic sclerosis pathogenesis
Yang, M. M., Boin, F., & Wolters, P. J. (2024) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000001061 · Cited by 6
Snoeck, H. (2025) · European Respiratory Journal · doi:10.1183/13993003.02083-2025 · Cited by 6
“Furthermore, patients with telomeres shorter than the 10th age-adjusted percentile for the general population constitute approximately half of sporadic IPF cases [60].”
Higuchi, T., Oka, S., Furukawa, H., Shimada, K., Tsunoda, S., Ito, S., Okamoto, A., Fujimori, M., Nakamura, T., Katayama, M., et al. (2023) · Genes · doi:10.3390/genes14112084 · Cited by 5
Mutairy, E. A., Qattan, S. M. A., Khalid, M., Al-Enazi, A. A., Al‐Saif, M., Imtiaz, F., Ramzan, K., Raveendran, V. V., Alaiya, A. A., Meyer, B. F., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1282868 · Cited by 5
The role of long noncoding RNA MEG3 in fibrosis diseases
Wu, W., Zhou, S., Fei, G., & Wang, R. (2024) · Postgraduate Medical Journal · doi:10.1093/postmj/qgad124 · Cited by 5
Larizza, L., & Colombo, E. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179387 · Cited by 4
Diet, lifestyle and telomere length: using Copula Graphical Models on NHANES data
Tedaldi, A. M., Behrouzi, P., & Grootswagers, P. (2025) · Aging · doi:10.18632/aging.206194 · Cited by 5
Sugino, S., Bortz, B., Vaida, S. J., Karamchandani, K., & Janicki, P. K. (2015) · A & A Case Reports · doi:10.1213/xaa.0000000000000198 · Cited by 4
Syndromes Associated with Telomere Shortening
Nag, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88792 · Cited by 7
Samarelli, A. V., Tonelli, R., Raineri, G., Bruzzi, G., Andrisani, D., Gozzi, F., Marchioni, A., Costantini, M., Fabbiani, L., Genovese, F., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1275346 · Cited by 5
“In addition, some genetic variants have also been associated with IPF onset and progression such as the mucin 5B (MUC5B) gene, involved in the maintenance of bronchoalveolar epithelial function (14 – 16), or TERT and TERC genes involved in the telomere length and maintenance (17 – 20).”
BackgroundTelomere Maintenance and Genome Stability
Hernandez-Sanchez, W. M., Xu, M., & Taylor, D. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00021-5 · Cited by 5
Metadata
- Authors
- Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., Phillips, J. A., Lansdorp, P. M., Loyd, J. E., & Armanios, M. Y.
- Affiliations
- Johns Hopkins University (US)
- Arizona State University (US)
- Vanderbilt University (US)
- BC Cancer Agency (CA)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13051-13056
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2529100
- OpenAlex
- W2147238277
- Cited by
- 805
- References
- 35
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 38 · 2023: 48 · 2022: 45 · 2021: 61 · 2020: 53 · 2019: 60 · 2018: 54 · 2017: 40 · 2016: 36 · 2015: 56 · 2014: 45 · 2013: 45 · 2012: 40
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Doris Duke Charitable Foundation
- Johns Hopkins University
- National Institutes of Health
- U.S. Public Health Service (T32 60441, K08 118416)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, idiopathic interstitial pneumonia, telomere length, short telomeres, telomerase mutations, hTERT, hTR, leukocytes, alveolar epithelial cells, cryptogenic cirrhosis, disease risk
- MeSH terms
- Epithelium, Family, Fibrosis, Heterozygote, Humans, Leukocytes, Mononuclear, Pulmonary Alveoli, Pulmonary Fibrosis, Risk Factors, RNA, Tomography, X-Ray Computed, Biomarkers, Case-Control Studies, Telomere, In Situ Hybridization, Fluorescence, Germ-Line Mutation, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.